CD22 Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignanciesCD22特异性T细胞受体使B细胞恶性肿瘤的过继性T细胞疗法成为可能。BloodIF23.12025-10-210PRE
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancerJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-05-0240OAAI
Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trialEUROPEAN JOURNAL OF CANCERIF7.12022-02-0116OAAI
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignanciesJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-07-309OAAI
Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challengesINTERNATIONAL JOURNAL OF CANCERIF4.72021-03-038OAAI